‘The problem is they’re just going to get Ventolin.’

Stakeholders including pharmacists are warning that the change to criteria for prescribing fluticasone propionate will hurt less wealthy families – especially as we head into winter A change to how a key asthma medication is subsidised has been badly communicated to pharmacists and GPs alike, they say, and may turn concession card holding families away